Regeneron Pharmaceuticals, Inc. Executive Outlines Strategy For...

For some larger employers, the next big issue in health insurance is the so-called Cadillac tax, a penalty on companies offering high-end health benefit packages to workers. That's according to Brian Fagan, who is associate director of benefits for Regeneron Pharmaceuticals Inc., the drug developer headquartered in Tarrytown, New York.

http://ift.tt/1tW7nJK